Viewing Study NCT02557620


Ignite Creation Date: 2025-12-25 @ 4:18 AM
Ignite Modification Date: 2026-02-28 @ 10:52 PM
Study NCT ID: NCT02557620
Status: COMPLETED
Last Update Posted: 2017-01-04
First Post: 2015-09-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparing Semaglutide Administered Subcutaneously Once Daily to Semaglutide Administered Subcutaneously Once Weekly
Sponsor: Novo Nordisk A/S
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes View
None Healthy View
Keywords: